3 completed, 1 withdrawn. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Withdrawn 1 |
Follow Infections, Bacterial: new trials by email Literature Review of Infections, Bacterial trials Research Report on Infections, Bacterial
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pharmacokinetics and Safety Study of Augmentin ES-600 in Children With CAP and ABRS Augmentin ES - Infections, Bacterial | Phase 2 | Withdrawn | GlaxoSmithKline | 2023-10-14 | 2025-03-28 | |
| Pharmacokinetic Study of Oral Gepotidacin (GSK2140944) in Subjects With Uncomplicated Urinary Tract Infection (Acute Cystitis) Gepotidacin - Infections, Bacterial | Phase 2 | Completed | GlaxoSmithKline | 22 | 2018-07-23 | 2020-06-29 |
| Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections GSK2140944 Lyophile, GSK2140944 Capsules - Infections, Bacterial | Phase 2 | Completed | GlaxoSmithKline | 126 | 2014-03-24 | 2017-11-17 |
| Retapamulin Ointment in Healthy Adults Nasally Colonized With Staphylococcus Aureus retapamulin, Retapamulin, Placebo - Infections, Bacterial | Phase 2 | Completed | GlaxoSmithKline | 57 | 2007-09-01 | 2016-12-15 |
Bacterial Infections (4) · Community-Acquired Pneumonia (1) · Infections (1) · Urinary Tract Infections (1)
Bacterial Infections and Mycoses (4) · Infections (3) · Community-Acquired Infections (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Male Urogenital Diseases (1) · Pneumonia (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Urogenital Diseases (1) · Urologic Diseases (1)
gepotidacin (2) · Amoxicillin-Potassium Clavulanate Combination (1) · retapamulin (1)
GlaxoSmithKline (4)
United States (3) · Brazil (1)